Publication:
Reproductive aspects of systemic lupus erythematosus

dc.contributor.coauthorN/A
dc.contributor.departmentN/A
dc.contributor.kuauthorÖktem, Özgür
dc.contributor.kuauthorYağmur, Hande
dc.contributor.kuauthorBengisu, Hale
dc.contributor.kuauthorUrman, Cumhur Bülent
dc.contributor.kuprofileFaculty Member
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.unitN/A
dc.contributor.unitKoç University Hospital
dc.contributor.unitKoç University Hospital
dc.contributor.unitN/A
dc.contributor.yokid102627
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokid12147
dc.date.accessioned2024-11-09T23:00:52Z
dc.date.issued2016
dc.description.abstractSystemic lupus erythematosus (SLE) is an auto-immune systemic disease showing a strong predilection for women of reproductive age. Higher prevalance of SLE among young women are in part accounted for by the effects of estrogen hormone on immune system. The key pathophysiological features of this disease are the generation of autoantibodies and the deposition of antibody-antigen complexes in the basal membranes of the organs where they evoke inflammatory responses and injury. Young females diagnosed with SLE are more prone to developing a multitude of adverse reproductive and obstetric outcomes, especially in the presence of active disease. Our motivation in writing this review article is to outline the recent interesting findings of molecular and clinical studies showing multi-faceted roles of estrogen hormone in both normal immune function and auto-immunity and to provide an update on the ovarian function and other poor reproductive outcomes in young females with SLE.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume117
dc.identifier.doi10.1016/j.jri.2016.07.001
dc.identifier.eissn1872-7603
dc.identifier.issn0165-0378
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-84979520834
dc.identifier.urihttp://dx.doi.org/10.1016/j.jri.2016.07.001
dc.identifier.urihttps://hdl.handle.net/20.500.14288/8138
dc.identifier.wos383817500010
dc.keywordsSystemic lupus erythematosus
dc.keywordsEstrogen
dc.keywordsImmunity
dc.keywordsReproductive outcome
dc.keywordsFertility preservation
dc.keywordsAmenorrhea
dc.keywordsInfertility
dc.keywordsChemotherapy
dc.keywordsLupus complications
dc.keywordsAnti-mullerian hormone
dc.keywordsFertility preservation
dc.keywordsDisease-activity
dc.keywordsOvarian failure
dc.keywordsCyclophosphamide therapy
dc.keywordsPulse cyclophosphamide
dc.keywordsMycophenolate-mofetil
dc.keywordsMaintenance treatment
dc.keywordsInduction Therapy
dc.keywordsAmerican-society
dc.languageEnglish
dc.publisherElsevier
dc.sourceJournal of Reproductive Immunology
dc.subjectImmunology
dc.subjectReproductive biology
dc.titleReproductive aspects of systemic lupus erythematosus
dc.typeReview
dspace.entity.typePublication
local.contributor.authorid0000-0003-1966-3886
local.contributor.authorid0000-0003-0974-5044
local.contributor.authoridN/A
local.contributor.authorid0000-0002-6076-6468
local.contributor.kuauthorÖktem, Özgür
local.contributor.kuauthorYağmur, Hande
local.contributor.kuauthorBengisu, Hale
local.contributor.kuauthorUrman, Cumhur Bülent

Files